Strengthening India's integrated HIV/STI tiered laboratory network through continuous quality improvement, surveillance, and laboratory data management under the President's Emergency Plan for AIDS Relief (PEPFAR)

The summary for the Strengthening India's integrated HIV/STI tiered laboratory network through continuous quality improvement, surveillance, and laboratory data management under the President's Emergency Plan for AIDS Relief (PEPFAR) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control-GHC, which is the U.S. government agency offering this grant.

Strengthening India's integrated HIV/STI tiered laboratory network through continuous quality improvement, surveillance, and laboratory data management under the President's Emergency Plan for AIDS Relief (PEPFAR): The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $1,000,000 for Year 1, subject to the availability of funds. You will support the National AIDS Control Program (NACP) under the Ministry of Health (MoH) to strengthen the national HIV/STI laboratory systems and services in India. This NOFO aims to maintain gains and strengthen the delivery of high-quality, integrated HIV/STI diagnostic services across the country through the following:Optimizing diagnostic networks to ensure efficiencies and testing accessibility through innovative strategies.Saturating viral load coverage (VLC).Improving biosafety.Achieving and maintaining International Organization for Standardization (ISO) accreditation and national certifications.Expanding proficiency testing (PT) programs to multiple testing parameters.Prioritizing the scaling of patient-centered approaches and point-of-care testing (POCT) to address the following:Barriers to access.Integration of multi-disease tests.Quality improvement, certification, and validation.Incorporating molecular epidemiology to pinpoint transmission networks and emerging needs.Conducting HIV drug resistance testing.Using implementation science to incorporate innovative laboratory models to improve detection, coverage, and access to HIV/STI diagnostic services.